Norethindrone Acetate And Ethinyl Estradiol Tablet
Product Images NDC 0378-7274

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate And Ethinyl Estradiol (NDC 0378-7274). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structures (17eb0f03 1827 4bd3 A633 390500bdf250 01)

Chemical structure diagrams of the active ingredients Ethinyl Estradiol and Norethindrone Acetate, showing their molecular configurations as found in the drug label for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL tablets by Mylan Pharmaceuticals Inc.*

FDA Label Image

Graph (17eb0f03 1827 4bd3 A633 390500bdf250 02)

Bar chart showing mortality rates (number of deaths per 100,000 woman users) by age group (15-24, 25-34, 35-44, 45+) comparing ever-users and controls for smokers and non-smokers. Mortality rates increase with age, with the highest rate seen in ever-smoker users aged 45 and above.*

FDA Label Image

Blister With Instructions (17eb0f03 1827 4bd3 A633 390500bdf250 03)

This is a dosing instruction label for norethindrone acetate and ethinyl estradiol tablets, USP, 1.5 mg/0.03 mg. It shows a 21-tablet weekly layout with days of the week from Sunday to Saturday arranged in three rows labeled Week 1 to Week 3. Instructions indicate starting for both Sunday starters and day-1 starters, with directional arrows guiding pill intake from left to right each week. It includes storage temperature information (20° to 25°C) and the NDC number 0378-7274-85.*

FDA Label Image

Day Sticker Label (17eb0f03 1827 4bd3 A633 390500bdf250 04)

An instructional diagram showing six strips of day labels starting with each day of the week from Monday through Saturday. Below the strips, a note titled DAY 1 START instructs to choose the label strip that corresponds to the first day of the user's period, to place it over the blister pack area with days of the week preprinted starting with Sunday, and notes that if the first day is Sunday, this step can be skipped.*

FDA Label Image

Blister With Instructions (17eb0f03 1827 4bd3 A633 390500bdf250 05)

A medication guide diagram for Norethindrone Acetate and Ethinyl Estradiol Tablets USP 1.5 mg/0.03 mg showing a 21-tablet weekly calendar. The layout indicates the order to take the pills from left to right, starting at Sunday of week 1 and proceeding through week 3. Instructions are included for day-1 starters and Sunday starters, with a note on placing the day label strip according to the first day of the period. Storage temperature guidance is also noted.*

FDA Label Image

Day Sticker Label (17eb0f03 1827 4bd3 A633 390500bdf250 06)

An instructional diagram showing seven day label strips with days of the week arranged in different sequences starting from Monday, Tuesday, Wednesday, Thursday, Friday, Saturday, and Sunday. Below the strips is a 'DAY 1 START' instruction guiding users to pick the label that begins with the first day of their period and place it over the blister card area with days preprinted starting Sunday, with a note about skipping the step if the period starts on a Sunday.*

FDA Label Image

3s Carton (Image 01)

Packaging label for Norethindrone Acetate and Ethinyl Estradiol tablets, USP, available in a strength of 1.5 mg / 0.03 mg. The label indicates oral tablets manufactured for Mylan Pharmaceuticals Inc. It notes each blister pack contains 21 blue tablets, and 3 pouches are included. The label includes dosage and storage instructions, with branding and barcodes present.*

FDA Label Image

Image 02

A forest plot chart illustrating effect estimates comparing combined oral contraceptive (COC) use versus never use across various studies. The x-axis represents the effect estimate ranging from -1.50 to 2.00. Studies are listed on the left with corresponding odds ratios (OR), relative risks (RR), and hazard ratios (HR) including confidence intervals on the right. Data points with confidence intervals are plotted around the effect estimate of 1.00, showing variation among studies.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.